First Light Asset Management, LLC - Q4 2015 holdings

$239 Million is the total value of First Light Asset Management, LLC's 65 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 19.2% .

 Value Shares↓ Weighting
LGND SellLIGAND PHARMACEUTICALS INC$6,160,000
+24.9%
56,818
-1.3%
2.58%
+5.9%
OXFD SellOXFORD IMMUNOTEC GLOBAL PLC$5,758,000
-18.1%
500,697
-3.9%
2.41%
-30.5%
DOC SellPHYSICIANS REALTY TRUST$5,358,000
+10.3%
317,817
-1.3%
2.24%
-6.5%
TEAR SellTEARLAB CORP$5,228,000
-30.9%
3,761,436
-0.1%
2.19%
-41.4%
ALKS SellALKERMES PLC$5,039,000
+33.9%
63,484
-1.0%
2.11%
+13.6%
INSM SellINSMED INC$4,583,000
-9.4%
252,495
-7.3%
1.92%
-23.2%
CYNA SellCYNAPSUS THERAPEUTICS INC$4,527,000
-7.3%
296,072
-2.0%
1.90%
-21.5%
QDEL SellQUIDEL CORP$4,139,000
+9.0%
195,243
-2.9%
1.73%
-7.5%
SPNC SellSPECTRANETICS CORP$4,002,000
+18.9%
265,762
-6.9%
1.68%
+0.8%
RTIX SellRTI BIOLOGICS INC$3,993,000
-64.8%
1,005,889
-49.6%
1.67%
-70.1%
VCYT SellVERACYTE INC$3,835,000
+44.7%
532,574
-5.7%
1.61%
+22.7%
CLDX SellCELLDEX THERAPEUTICS INC$3,267,000
+44.0%
208,343
-3.2%
1.37%
+22.1%
ANGO SellANGIODYNAMICS INC$3,182,000
-13.0%
262,089
-5.5%
1.33%
-26.2%
VRTX SellVERTEX PHARMACEUTICALS INC$3,060,000
+19.3%
24,320
-1.3%
1.28%
+1.1%
ARWR SellARROWHEAD RESEARCH CORP$2,848,000
+6.2%
463,140
-0.5%
1.19%
-9.9%
HSTM SellHEALTHSTREAM INC$2,574,000
-0.3%
117,006
-1.1%
1.08%
-15.5%
ARRY SellARRAY BIOPHARMA INC$2,238,000
-50.4%
530,391
-46.3%
0.94%
-57.9%
TECH SellBIO TECHNE CORP$2,210,000
-56.0%
24,556
-54.8%
0.93%
-62.6%
CPHD SellCEPHEID$2,181,000
-24.9%
59,691
-7.1%
0.91%
-36.4%
KPTI SellKARYOPHARM THERAPEUTICS INC$2,024,000
+24.2%
152,765
-1.3%
0.85%
+5.3%
BMRN SellBIOMARIN PHARMACEUTICAL INC$1,980,000
-1.8%
18,901
-1.3%
0.83%
-16.8%
STKL ExitSUNOPTA INCcs$0-50,230
-100.0%
-0.12%
CYH ExitCOMMUNITY HEALTH SYS INC NEWcs$0-6,145
-100.0%
-0.13%
ESPR ExitESPERION THERAPEUTICS INC NEcs$0-47,965
-100.0%
-0.56%
OMCL ExitOMNICELL INCcs$0-172,429
-100.0%
-2.65%
IG ExitIGI INCcs$0-1,011,217
-100.0%
-3.27%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-02-12
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ATRICURE INC40Q3 20239.7%
NEOGENOMICS INC40Q3 202310.6%
SANOFI-SYNTHELABO40Q3 20231.9%
JOHNSON & JOHNSON40Q3 20230.3%
PFIZER INC39Q2 20230.9%
BIOMARIN PHARMACEUTICAL INC36Q3 20231.6%
OMNICELL INC33Q3 20237.7%
QUIDEL CORP33Q4 20213.7%
NOVARTIS AG-SPONSORED ADR33Q3 20230.4%
MODEL N INC30Q3 20239.0%

View First Light Asset Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
First Light Asset Management, LLC Q4 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
REATA PHARMACEUTICALS INCMay 15, 20231,290,1933.9%
Axogen, Inc.February 03, 20231,942,2704.6%
MODEL N, INC.February 03, 20231,845,1344.9%
MEI Pharma, Inc.Sold outMay 31, 202200.0%
PROTHENA CORP PUBLIC LTD COMarch 01, 20221,805,0383.9%
Intersect ENT, Inc.February 14, 20221,375,2104.1%
SeaSpine Holdings CorpFebruary 14, 20226,847,70718.8%
Oxford Immunotec Global PLCSold outFebruary 10, 202100.0%
ENDOLOGIX INC /DE/February 14, 2020816,2364.6%
Nuvectra CorpSold outFebruary 14, 202000.0%

View First Light Asset Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-06-10
SC 13G/A2024-06-10
13F-HR2024-05-15
SC 13D/A2024-04-09
42024-04-08
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14

View First Light Asset Management, LLC's complete filings history.

Compare quarters

Export First Light Asset Management, LLC's holdings